Cost Effectiveness of Free Access to Smoking Cessation Treatment in France Considering the Economic Burden of Smoking-Related Diseases.

about

Experiences of COPD patients with existing smoking cessation programs and their preferences for improvement - a qualitative analysis.Development and Application of an Economic Model (EQUIPTMOD) to assess the Impact of Smoking Cessation.

P2860

Q37203331-22451D57-5096-4D38-A67A-70CCBEBB048D Q38611963-66CEDC9E-086A-471D-8756-FB138A7717D3

P2860

Cost Effectiveness of Free Access to Smoking Cessation Treatment in France Considering the Economic Burden of Smoking-Related Diseases.

Item

http://www.wikidata.org/entity/Q35933786

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Cost Effectiveness of Free Acc ...... n of Smoking-Related Diseases.

@ast

Cost Effectiveness of Free Acc ...... n of Smoking-Related Diseases.

@en

type

Item

label

Cost Effectiveness of Free Acc ...... n of Smoking-Related Diseases.

@ast

Cost Effectiveness of Free Acc ...... n of Smoking-Related Diseases.

@en

prefLabel

Cost Effectiveness of Free Acc ...... n of Smoking-Related Diseases.

@ast

Cost Effectiveness of Free Acc ...... n of Smoking-Related Diseases.

@en

P1476

Cost Effectiveness of Free Acc ...... n of Smoking-Related Diseases.

@en

P2093

Benjamin Cadier

http://www.w3.org/2001/XMLSchema#string

Daniel Thomas

http://www.w3.org/2001/XMLSchema#string

Isabelle Durand-Zaleski

http://www.w3.org/2001/XMLSchema#string

Karine Chevreul

http://www.w3.org/2001/XMLSchema#string

P2860

Individual behavioural counselling for smoking cessation

Mortality in relation to smoking: 50 years' observations on male British doctors

Mortality in relation to smoking: 40 years' observations on male British doctors

Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials.

Simulation-based estimates of effectiveness and cost-effectiveness of smoking cessation in patients with chronic obstructive pulmonary disease.

The impact of the United Kingdom's national smoking cessation strategy on quit attempts and use of cessation services: findings from the International Tobacco Control Four Country Survey.

The English smoking treatment services: one-year outcomes.

The Quit Benefits Model: a Markov model for assessing the health benefits and health care cost savings of quitting smoking.

Costs and benefits of smoking cessation aids: making a case for public reimbursement of nicotine replacement therapy in Australia.

Life expectancy and years of life lost in chronic obstructive pulmonary disease: findings from the NHANES III Follow-up Study

P304

e0148750

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0148750

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Isabelle Durand-Zaleski

P577

2016-02-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

295891790

http://www.w3.org/2001/XMLSchema#string

P698

26909802

http://www.w3.org/2001/XMLSchema#string

P932

4766094

http://www.w3.org/2001/XMLSchema#string

Cost Effectiveness of Free Access to Smoking Cessation Treatment in France Considering the Economic Burden of Smoking-Related Diseases.

about

P2860

P2860

Cost Effectiveness of Free Access to Smoking Cessation Treatment in France Considering the Economic Burden of Smoking-Related Diseases.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932